All Stories

  1. Provocative testing in community dwelling older adults: a path to identify physical resilience
  2. Effects of a 6-Week Treadmill Training With and Without Virtual Reality on Frailty in People With Multiple Sclerosis
  3. Frailty in multiple sclerosis: A scoping review
  4. VO2MAX, 6-minute walk, and muscle strength each correlate with frailty in US veterans
  5. Age‐related increase of CD38 directs osteoclastogenic potential of monocytic myeloid‐derived suppressor cells through mitochondrial dysfunction in male mice
  6. Multimodal Exercise Training to Reduce Frailty in People with Multiple Sclerosis: Study Protocol for a Pilot Randomized Controlled Trial
  7. Multimodal exercise training to reduce frailty in people with multiple sclerosis: study protocol for a pilot randomized controlled trial
  8. The Relationships between Caregiver Burden, Physical Frailty, Race, Behavioral and Psychological Symptoms (BPSD), and Other Associated Variables: An Exploratory Study
  9. Proline restores mitochondrial function and reverses aging hallmarks in senescent cells
  10. Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid‐derived suppressor cells
  11. Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle
  12. Inhibition of glutaminolysis restores mitochondrial function in senescent stem cells
  13. Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells
  14. World guidelines for falls prevention and management for older adults: a global initiative
  15. HIIT, Sleep and Cognition in Older Adults
  16. Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations
  17. Front Matter
  18. Frailty: The end of the osteosarcopenia continuum?
  19. Both Vitamin D Supplementation and HIIT Boost Muscle VDR Expression, Which May Underlie Benefits for Frailty
  20. Ameliorating the hallmarks of cellular senescence in skeletal muscle myogenic progenitors in vitro and in vivo
  21. Short-term nicotinamide riboside treatment improves muscle quality and function in mice and increases cellular energetics and differentiating capacity of myogenic progenitors
  22. Falls: To D or Not to D—That Is Not the (Only) Question!
  23. The Association of Muscle Mass Measured by D3-Creatine Dilution Method With Dual-Energy X-Ray Absorptiometry and Physical Function in Postmenopausal Women
  24. Pinpointing a Role for Vitamin D in Frailty: A Time for Animal Models?
  25. SRT2183 and SRT1720, but not Resveratrol, Inhibit Osteoclast Formation and Resorption in the Presence or Absence of Sirt1
  26. Vitamin D Insufficiency Reduces Grip Strength, Grip Endurance and Increases Frailty in Aged C57Bl/6J Mice
  27. Absence of complement factor H reduces physical performance in C57BL6 mice
  28. Racial Disparities in a Sample of Inpatient Youth with ASD
  29. AGS and NIA Bench‐to Bedside Conference Summary: Osteoporosis and Soft Tissue (Muscle and Fat) Disorders
  30. Investigating and Remediating Selection Bias in Geriatrics Research: The Selection Bias Toolkit
  31. High intensity interval training improves physical performance in aged female mice: A comparison of mouse frailty assessment tools
  32. Treatment with an inhibitor of fatty acid synthase attenuates bone loss in ovariectomized mice
  33. AP‐1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors
  34. Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice
  35. Absence of complement factor H alters bone architecture and dynamics
  36. Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility
  37. Chronic vitamin D insufficiency impairs physical performance in C57BL/6J mice
  38. Methamphetamine Induces Apoptosis of Microglia via the Intrinsic Mitochondrial-Dependent Pathway
  39. Micro-CT analysis of trabecular parameters gradients in femurs of mice affected by chronic kidney disease
  40. Neuropeptide Y Y2 antagonist treated ovariectomized mice exhibit greater bone mineral density
  41. Sleep Problems and Their Relationship to Maladaptive Behavior Severity in Psychiatrically Hospitalized Children with Autism Spectrum Disorder (ASD)
  42. Verbal Ability and Psychiatric Symptoms in Clinically Referred Inpatient and Outpatient Youth with ASD
  43. Talking About Death or Suicide: Prevalence and Clinical Correlates in Youth with Autism Spectrum Disorder in the Psychiatric Inpatient Setting
  44. High Intensity Interval Training Improves Physical Performance and Frailty in Aged Mice
  45. Problem Behaviors in Autism Spectrum Disorder: Association with Verbal Ability and Adapting/Coping Skills
  46. Predictors of Inpatient Psychiatric Hospitalization for Children and Adolescents with Autism Spectrum Disorder
  47. A mouse model of vitamin D insufficiency: is there a relationship between 25(OH) vitamin D levels and obesity?
  48. Cellular and Molecular Aging
  49. Calciotropic Hormones
  50. Mouse Models of Frailty: an Emerging Field
  51. Statement of Principle
  52. Vitamin D: A Regulator of Metabolism and Inflammation
  53. Resveratrol: Effects on Lipids and Cardiovascular Risk
  54. Do Vitamin D Levels Influence the Risk of Diabetes Mellitus and Play a Role in Healthier Aging?
  55. 3. Impact of Vitamin D on the Aging Population
  56. Retinoic acid inhibits NFATc1 expression and osteoclast differentiation
  57. The Response of Elderly Veterans to Daily Vitamin D3 Supplementation of 2,000 IU: A Pilot Efficacy Study
  58. Cell and Molecular Aging
  59. Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention
  60. The cathepsin L gene is a direct target of FOXO1 in skeletal muscle
  61. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand
  62. Vitamin D Supplementation in Older Persons: Benefits and Requirements
  63. Some new food for thought: The role of vitamin D in the mental health of older adults
  64. Calciotropic Hormones
  65. Hypovitaminosis D in the elderly: From bone to brain
  66. ERRATUM
  67. Understanding the Mechanisms of Senile Osteoporosis: New Facts for a Major Geriatric Syndrome
  68. Fat and Inflammaging: A Dual Path to Unfitness in Elderly People?
  69. Functional grouping of osteoclast genes revealed through microarray analysis
  70. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells
  71. RESPONSE LETTER TO DRS. FISHER AND DAVIS
  72. Osteoporosis in Older People: A Tale of Two Studies (and Three Treatments)
  73. The Regulation of Cathepsin K Gene Expression
  74. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells
  75. RANK-L induces the expression of NFATc1, but not of NFκB subunits during osteoclast formation
  76. The role of cathepsin K in normal bone resorption
  77. Molecular mechanisms underlying osteoclast formation and activation
  78. Molecular cloning, expression, and function of osteoclastic calcineurin Aα
  79. Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts
  80. Cathepsin K, Osteoclastic Resorption, and Osteoporosis Therapy
  81. Macrophage Colony-Stimulating Factor Suppresses Osteoblast Formation
  82. New Insights into the Regulation of Cathepsin K Gene Expression by Osteoprotegerin Ligand
  83. Cell and Molecular Aging
  84. Transcription of Human Cathepsin B Is Mediated by Sp1 and Ets Family Factors in Glioma
  85. Differentiating agents regulate cathepsin B gene expression in HL-60 cells
  86. Cd38/Adp-Ribosyl Cyclase
  87. Comparative responsiveness of HL-60, HL-60R, and HL-60R+ (LRARSN) cells to retinoic acid, calcitriol, 9 cis-retinoic acid, and sodium butyrate
  88. Cloning, genomic organization, and chromosomal localization of human cathepsin L.
  89. Use of a cloned multidrug resistance gene for coamplification and overproduction of major excreted protein, a transformation-regulated secreted acid protease.
  90. Use of a Cloned Multidrug Resistance Gene for Coamplification and Overproduction of Major Excreted Protein, a Transformation-Regulated Secreted Acid Protease
  91. Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation.
  92. Sequence and expression of the cDNA for MEP (major excreted protein), a transformation-regulated secreted cathepsin
  93. [30] Colony screening of genomic cosmid libraries
  94. Effect of age on the 3,5,3′-tri-iodothyronine-induced increase in sugar uptake in rat thymocytes
  95. Influence of age and sex on the concentrations of thyroid hormone in serum in the rat
  96. Sympathetic Nervous System and Aging in Man
  97. Plasma epinephrine and control of plasma renin activity: possible extrarenal mechanisms
  98. Studies of the human testis
  99. Studies of the Human Testis. III. Effect of Estrogen on Testosterone Formation in Human Testisin Vitro